Title:
PYRIMIDINONE DERIVATIVE AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USE
Document Type and Number:
WIPO Patent Application WO/2022/233302
Kind Code:
A1
Abstract:
The present invention provides a compound as represented by general formula (I), a cis-trans isomer thereof, an enantiomer thereof, a diastereomer thereof, a racemate thereof, a solvate thereof, a hydrate thereof, or a pharmaceutically-acceptable salt thereof or a prodrug thereof, a preparation method therefor, a pharmaceutical composition containing the compound, and a use of the compound as an Lp-PLA2 inhibitor, wherein R1, R2, Rx, Ry, Rz, Q, U, X, m, n, and A are defined in the description.
Inventors:
JIN YUN (CN)
PENG JUN (CN)
PENG JUN (CN)
Application Number:
PCT/CN2022/090984
Publication Date:
November 10, 2022
Filing Date:
May 05, 2022
Export Citation:
Assignee:
SHANGHAI SIMR BIOTECHNOLOGY CO LTD (CN)
SHANGHAI SIMRD BIOTECHNOLOGY CO LTD (CN)
SHANGHAI SIMRD BIOTECHNOLOGY CO LTD (CN)
International Classes:
C07D498/22; A61K31/519; A61K31/529; A61K31/5383; A61P3/10; A61P7/10; A61P9/10; A61P13/12; A61P21/00; A61P25/00; A61P25/04; A61P25/16; A61P25/28; C07D471/14; C07D487/14; C07D487/18; C07D498/14
Domestic Patent References:
WO2016011930A1 | 2016-01-28 | |||
WO1996013484A1 | 1996-05-09 | |||
WO1996019451A1 | 1996-06-27 | |||
WO1997002242A1 | 1997-01-23 | |||
WO1997012963A2 | 1997-04-10 | |||
WO1997021675A1 | 1997-06-19 | |||
WO1997021676A1 | 1997-06-19 | |||
WO1997041098A1 | 1997-11-06 | |||
WO1997041099A1 | 1997-11-06 | |||
WO1999002442A1 | 1999-01-21 | |||
WO2000010980A1 | 2000-03-02 | |||
WO2000066566A1 | 2000-11-09 | |||
WO2000066567A1 | 2000-11-09 | |||
WO2000068208A1 | 2000-11-16 | |||
WO2001060805A1 | 2001-08-23 | |||
WO2002030904A1 | 2002-04-18 | |||
WO2002030911A1 | 2002-04-18 | |||
WO2003015786A1 | 2003-02-27 | |||
WO2003016287A2 | 2003-02-27 | |||
WO2003041712A1 | 2003-05-22 | |||
WO2003042179A1 | 2003-05-22 | |||
WO2003042206A1 | 2003-05-22 | |||
WO2003042218A1 | 2003-05-22 | |||
WO2003086400A1 | 2003-10-23 | |||
WO2003087088A2 | 2003-10-23 | |||
WO2008004886A1 | 2008-01-10 | |||
WO2008048866A2 | 2008-04-24 | |||
WO2005003118A1 | 2005-01-13 | |||
WO2006063811A2 | 2006-06-22 | |||
WO2006063813A2 | 2006-06-22 | |||
WO2008141176A1 | 2008-11-20 | |||
WO2013013503A1 | 2013-01-31 | |||
WO2013014185A1 | 2013-01-31 | |||
WO2014114248A1 | 2014-07-31 | |||
WO2014114694A1 | 2014-07-31 | |||
WO2016011930A1 | 2016-01-28 | |||
WO1999024420A1 | 1999-05-20 | |||
WO2008048867A2 | 2008-04-24 | |||
WO2012080497A2 | 2012-06-21 | |||
WO1997002037A1 | 1997-01-23 | |||
WO1998028310A1 | 1998-07-02 | |||
WO1998028311A1 | 1998-07-02 | |||
WO1998028312A1 | 1998-07-02 |
Foreign References:
CN113912622A | 2022-01-11 | |||
CN112778331A | 2021-05-11 | |||
CN112574221A | 2021-03-30 | |||
US20080103156A1 | 2008-05-01 | |||
US20080090851A1 | 2008-04-17 | |||
US20080090852A1 | 2008-04-17 | |||
JP2001088847A | 2001-04-03 | |||
US20080279846A1 | 2008-11-13 | |||
US20100239565A1 | 2010-09-23 | |||
US20080280829A1 | 2008-11-13 | |||
US20080279846A1 | 2008-11-13 | |||
CA2530816A1 | 2005-01-13 |
Other References:
ZALEWSKI A ET AL., ARTERIOSCLER. THROMB., vol. 25, no. 5, 2005, pages 923 - 31
WILENSKY ET AL., NATURE MEDICINE, vol. 10, 2008, pages 1015 - 1016
SERRUYS ET AL., CIRCULATION, vol. 118, 2008, pages 1172 - 1182
VAN OIJEN ET AL., ANNALS OF NEUROLOGY, vol. 59, 2006, pages 139
FITZPATRICK ET AL., ATHEROSCLEROSIS, vol. 235, 2014, pages 384 - 391
KASSNER ET AL., CURRENT ALZHEIMER RESEARCH, vol. 5, 2008, pages 358 - 366
DILDAR ET AL., ALZHEIMER DIS ASSOC DISORD, vol. 24, April 2010 (2010-04-01)
SINEM ET AL., CURRENT ALZHEIMER RESEARCH, vol. 7, 2010, pages 463 - 469
MAHER-EDWARDS ET AL., ALZHEIMER'S & DEMENTIA: TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, vol. 1, 2015, pages 131 - 140
PERRY, ACTA NEUROPATHOL, vol. 120, 2010, pages 277 - 286
SHI ET AL., ATHEROSCLEROSIS, vol. 191, 2007, pages 54 - 62
WILENSKY ET AL., CURRENT OPINION IN LIPIDOLOGY, vol. 20, 2009, pages 415 - 420
SIDDIQUI ET AL., DIABETOLOGIA, vol. 61, 2018, pages 1344 - 1353
CANNING ET AL., P.N.A.S., vol. 113, 2016, pages 7213 - 7218
STAURENGHI ET AL., OPHTHALMOLOGY, vol. 122, 2015, pages 990 - 996
SERBAN ET AL., J. CELL. MOL. MED., vol. 6, 2002, pages 643 - 647
GARG ET AL., INDIAN J. MED. RES., vol. 141, 2015, pages 107 - 114
BUSCHINI ET AL., PROGRESS IN NEUROBIOLOGY, vol. 95, 2011, pages 14 - 25
TEZEL, PROGRESS IN BRAIN RESEARCH, vol. 173, ISSN: 0079-6123
OTUNCTEMUR ET AL., ANDROLOGIA, vol. 47, 2015, pages 706 - 710
VAINIO ET AL., ONCOTARGET, vol. 2, 2011, pages 1176 - 1190
BERGE ET AL., J. PHARM, SCI., vol. 66, 19 January 1977 (1977-01-19)
P L GOULD, INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 33, 1986, pages 201 - 217
BIGHLEY ET AL.: "Encyclopedia of Pharmaceutical Technology", vol. 13, 1996, MARCEL DEKKER INC, pages: 453 - 497
I.GREENEP.WUTS: "Protecting Groups in Chemical Synthesis", 1999, JOHN WILEY&SONS
"The Handbook of Pharmaceutical Excipients", AMERICAN PHARMACOLOGICAL ASSOCIATION AND DRUG PRESS
WILENSKY ET AL., NATURE MEDICINE, vol. 10, 2008, pages 1015 - 1016
SERRUYS ET AL., CIRCULATION, vol. 118, 2008, pages 1172 - 1182
VAN OIJEN ET AL., ANNALS OF NEUROLOGY, vol. 59, 2006, pages 139
FITZPATRICK ET AL., ATHEROSCLEROSIS, vol. 235, 2014, pages 384 - 391
KASSNER ET AL., CURRENT ALZHEIMER RESEARCH, vol. 5, 2008, pages 358 - 366
DILDAR ET AL., ALZHEIMER DIS ASSOC DISORD, vol. 24, April 2010 (2010-04-01)
SINEM ET AL., CURRENT ALZHEIMER RESEARCH, vol. 7, 2010, pages 463 - 469
MAHER-EDWARDS ET AL., ALZHEIMER'S & DEMENTIA: TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, vol. 1, 2015, pages 131 - 140
PERRY, ACTA NEUROPATHOL, vol. 120, 2010, pages 277 - 286
SHI ET AL., ATHEROSCLEROSIS, vol. 191, 2007, pages 54 - 62
WILENSKY ET AL., CURRENT OPINION IN LIPIDOLOGY, vol. 20, 2009, pages 415 - 420
SIDDIQUI ET AL., DIABETOLOGIA, vol. 61, 2018, pages 1344 - 1353
CANNING ET AL., P.N.A.S., vol. 113, 2016, pages 7213 - 7218
STAURENGHI ET AL., OPHTHALMOLOGY, vol. 122, 2015, pages 990 - 996
SERBAN ET AL., J. CELL. MOL. MED., vol. 6, 2002, pages 643 - 647
GARG ET AL., INDIAN J. MED. RES., vol. 141, 2015, pages 107 - 114
BUSCHINI ET AL., PROGRESS IN NEUROBIOLOGY, vol. 95, 2011, pages 14 - 25
TEZEL, PROGRESS IN BRAIN RESEARCH, vol. 173, ISSN: 0079-6123
OTUNCTEMUR ET AL., ANDROLOGIA, vol. 47, 2015, pages 706 - 710
VAINIO ET AL., ONCOTARGET, vol. 2, 2011, pages 1176 - 1190
BERGE ET AL., J. PHARM, SCI., vol. 66, 19 January 1977 (1977-01-19)
P L GOULD, INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 33, 1986, pages 201 - 217
BIGHLEY ET AL.: "Encyclopedia of Pharmaceutical Technology", vol. 13, 1996, MARCEL DEKKER INC, pages: 453 - 497
I.GREENEP.WUTS: "Protecting Groups in Chemical Synthesis", 1999, JOHN WILEY&SONS
"The Handbook of Pharmaceutical Excipients", AMERICAN PHARMACOLOGICAL ASSOCIATION AND DRUG PRESS
Attorney, Agent or Firm:
SUNSHINE INTELLECTUAL PROPERTY INTERNATIONAL CO., LTD. (CN)
Download PDF:
Previous Patent: CONTROL METHOD AND APPARATUS FOR APPLICATION PROGRAMS
Next Patent: ATOMIZER AND ELECTRONIC ATOMIZATION DEVICE
Next Patent: ATOMIZER AND ELECTRONIC ATOMIZATION DEVICE